Status:
COMPLETED
Effect of High Velocity/Hyperoxic Breathing Therapy on Blood Lactate Decline
Lead Sponsor:
Vapotherm, Inc.
Collaborating Sponsors:
Auburn University
Conditions:
Dyspnea
Lactic Acidosis
Eligibility:
All Genders
18-30 years
Phase:
NA
Brief Summary
The study will evaluate the impact of high velocity therapy (HVT) on reduction of work of breathing (as implied by breath frequency) and enhanced blood lactate decline during recovery from a Wingate-t...
Detailed Description
HVT has been found to be a useful clinical tool for treatment of Type 1 and Type 2 respiratory failure (including hypercapnic respiratory failure), acute decompensated heart failure, and COVID respira...
Eligibility Criteria
Inclusion
- Adults18-30 years old, in a general state of good health, of either sex
- No known contraindication to performing a maximal exercise test, i.e., Wingate-type Anaerobic exercise test
- Participants must consider themselves able to perform "regular moderate" or "regular strenuous" exercise.
- ° "Regular moderate" exercise includes less than 30 minutes every day or 30 minutes every other day, of some form of deliberate exercise, that does not include walking.
- ° "Regular strenuous" exercise is 30+ minutes per day, of some form of deliberate exercise, that does not include walking.
Exclusion
- Not considered a 'high-performance athlete'
- Known active cardiovascular, metabolic, liver, or renal disease
- Orthopedic limitations to exercise
- Pregnancy
- Use of beta-blockers or beta-agonist asthma medications
- Exercise induced asthma
- Any other health-related issue that would involve the participant's fitness capability
- Inability to complete all of the study procedures
Key Trial Info
Start Date :
March 6 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT05984186
Start Date
March 6 2023
End Date
December 31 2023
Last Update
October 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Auburn University
Auburn, Alabama, United States, 36849